Enzyme ChE, cholinergic therapy and molecular docking: Significant considerations and future perspectives.

Snežana M Jovičić
Author Information
  1. Snežana M Jovičić: Department of Genetics, Faculty of Biology, University of Belgrade, Belgrade, Serbia. ORCID

Abstract

Enzyme Che plays an essential role in cholinergic and non-cholinergic functions. It is present in the fertilized/unfertilized eggs and sperm of different species. Inclusion criteria for data collection from electronic databases NCBI and Google Scholar are enzyme AChE/BChE, cholinergic therapy, genomic organization and gene transcription, enzyme structure, biogenesis, transport, processing and localization, molecular signaling and biological function, polymorphism and influencing factors. Enzyme Che acts as a signaling receptor during hematopoiesis, protein adhesion, amyloid fiber formation, neurite outgrowth, bone development, and maturation, explaining the activity out of synaptic neurotransmission. Polymorphism in the Che genes correlates to various diseases and diverse drug responses. In particular, change accompanies cancer, neurodegenerative, and cardiovascular disease. Literature knowledge indicates the importance of Che inhibitors that influence biochemical and molecular pathways in disease treatment, genomic organization, gene transcription, structure, biogenesis, transport, processing, and localization of Che enzyme. Enzyme Che polymorphism changes indicate the possibility of efficient and new inhibitor drug target mechanisms in diverse research areas.

Keywords

References

  1. Nat Rev Neurosci. 2003 Feb;4(2):131-8 [PMID: 12563284]
  2. Acta Pharm Sin B. 2023 Oct;13(10):3988-4024 [PMID: 37799389]
  3. J Comput Chem. 2005 Dec;26(16):1701-18 [PMID: 16211538]
  4. JACS Au. 2024 Apr 01;4(4):1632-1645 [PMID: 38665669]
  5. Front Cell Dev Biol. 2021 Jan 28;8:620543 [PMID: 33585459]
  6. Chem Biol Interact. 2019 Aug 1;308:317-322 [PMID: 31170385]
  7. World J Exp Med. 2024 Mar 20;14(1):87202 [PMID: 38590305]
  8. J Pharmacol Sci. 2017 May;134(1):1-21 [PMID: 28552584]
  9. J Biol Chem. 2019 Apr 19;294(16):6253-6272 [PMID: 30787102]
  10. Biomarkers. 2019 Jun;24(4):317-324 [PMID: 30512980]
  11. Adv Nutr. 2023 Jul;14(4):819-839 [PMID: 37075947]
  12. Molecules. 2019 Jul 15;24(14): [PMID: 31311169]
  13. Brain Pathol. 2019 Jul;29(4):502-512 [PMID: 30511454]
  14. Chem Biol Interact. 1999 May 14;119-120:29-42 [PMID: 10421436]
  15. Protein Pept Lett. 2012 Feb;19(2):155-64 [PMID: 21933123]
  16. J Cheminform. 2024 May 28;16(1):62 [PMID: 38807196]
  17. Mol Divers. 2024 Mar 30;: [PMID: 38554169]
  18. Drug Des Devel Ther. 2018 Mar 09;12:505-512 [PMID: 29563775]
  19. Environ Int. 2021 Jan;146:106257 [PMID: 33395925]
  20. J Tradit Complement Med. 2016 Jun 06;7(1):106-109 [PMID: 28053895]
  21. Curr Opin Struct Biol. 2020 Dec;65:209-216 [PMID: 33171388]
  22. Metabolites. 2023 May 02;13(5): [PMID: 37233666]
  23. BMC Bioinformatics. 2023 Mar 22;24(1):107 [PMID: 36949402]
  24. Biochem Pharmacol. 2018 Jul;153:205-216 [PMID: 29409903]
  25. Environ Res. 2023 Mar 1;220:115195 [PMID: 36592809]
  26. Nucleic Acids Res. 2017 Feb 17;45(3):1455-1468 [PMID: 28180311]
  27. Pharmaceuticals (Basel). 2023 Sep 06;16(9): [PMID: 37765069]
  28. J Neurochem. 2017 Aug;142 Suppl 2:73-81 [PMID: 28382676]
  29. Biomed Pharmacother. 2022 Oct;154:113611 [PMID: 36081288]
  30. Philos Trans R Soc Lond B Biol Sci. 2018 Aug 19;373(1753): [PMID: 29967306]
  31. Sci Rep. 2018 Oct 8;8(1):14921 [PMID: 30297729]
  32. Molecules. 2022 Oct 14;27(20): [PMID: 36296489]
  33. Pharmgenomics Pers Med. 2021 May 28;14:631-653 [PMID: 34093032]
  34. Curr Drug Targets. 2017;18(10):1179-1190 [PMID: 26424395]
  35. Pharmaceuticals (Basel). 2024 May 08;17(5): [PMID: 38794168]
  36. Chem Biol Interact. 2019 Aug 25;309:108698 [PMID: 31176713]
  37. Toxicology. 2009 May 17;259(3):133-9 [PMID: 19428953]
  38. J Extracell Vesicles. 2019 Jul 03;8(1):1628592 [PMID: 31303981]
  39. Chem Biol Interact. 2010 Sep 6;187(1-3):10-22 [PMID: 20138030]
  40. Pharmaceuticals (Basel). 2024 Jan 30;17(2): [PMID: 38399389]
  41. J Mol Graph Model. 2012 Sep;38:194-210 [PMID: 23073222]
  42. Phys Chem Chem Phys. 2024 Mar 27;26(13):10323-10335 [PMID: 38501198]
  43. Neuron. 2018 Sep 19;99(6):1129-1143 [PMID: 30236283]
  44. Transl Psychiatry. 2016 May 03;6:e801 [PMID: 27138800]
  45. Sci Rep. 2021 Jan 11;11(1):398 [PMID: 33432008]
  46. Molecules. 2023 Jan 21;28(3): [PMID: 36770750]
  47. Curr Alzheimer Res. 2005 Apr;2(2):207-18 [PMID: 15974920]
  48. J Enzyme Inhib Med Chem. 2021 Dec;36(1):491-496 [PMID: 33478277]
  49. Biomolecules. 2020 Mar 07;10(3): [PMID: 32155996]
  50. Ir J Med Sci. 2023 Jun;192(3):1311-1319 [PMID: 35792997]
  51. Biomolecules. 2024 May 01;14(5): [PMID: 38785951]
  52. Front Mol Biosci. 2023 Jan 12;9:1070328 [PMID: 36710877]
  53. Cells. 2022 Jul 15;11(14): [PMID: 35883653]
  54. Front Pharmacol. 2018 Oct 18;9:1192 [PMID: 30405413]
  55. Toxicol Lett. 2017 Aug 5;277:24-31 [PMID: 28465191]
  56. J Neurochem. 2018 Aug;146(4):390-402 [PMID: 29675901]
  57. CCF Trans High Perform Comput. 2022;4(1):63-74 [PMID: 35039800]
  58. Biomed Chromatogr. 2011 Jan;25(1-2):278-99 [PMID: 21154892]
  59. Pharmaceuticals (Basel). 2022 May 23;15(5): [PMID: 35631472]
  60. Parasitol Int. 2020 Jun;76:102066 [PMID: 32006676]
  61. Cells. 2021 May 25;10(6): [PMID: 34070275]
  62. Commun Integr Biol. 2024 May 28;17(1):2353200 [PMID: 38827581]
  63. Nutrients. 2024 Apr 26;16(9): [PMID: 38732545]
  64. Nutrients. 2019 Aug 16;11(8): [PMID: 31426423]
  65. ACS Med Chem Lett. 2020 Mar 10;11(10):1810-1819 [PMID: 33062158]
  66. J Biochem Mol Toxicol. 2017 Sep;31(9): [PMID: 28544359]
  67. Acc Chem Res. 2024 Feb 9;: [PMID: 38333993]
  68. Int J Mol Sci. 2021 Feb 18;22(4): [PMID: 33670778]
  69. ChemCatChem. 2020 Oct 6;12(19):4704-4720 [PMID: 33897908]
  70. Biomed Pharmacother. 2023 Oct;166:115406 [PMID: 37659206]
  71. Ann Biol Clin (Paris). 2016 Jun 1;74(3):279-85 [PMID: 27237801]
  72. Molecules. 2020 Dec 08;25(24): [PMID: 33302541]
  73. J Neurochem. 2017 Aug;142 Suppl 2:52-58 [PMID: 28326552]
  74. Molecules. 2021 Apr 30;26(9): [PMID: 33946559]
  75. Bioessays. 2022 Sep;44(9):e2200060 [PMID: 35843871]
  76. Curr Ther Res Clin Exp. 2003 Apr;64(4):216-35 [PMID: 24944370]
  77. JNMA J Nepal Med Assoc. 2023 Jan 01;61(257):72-75 [PMID: 37203908]
  78. Bioorg Chem. 2019 Mar;84:511-517 [PMID: 30605787]
  79. Front Immunol. 2021 Apr 15;12:660342 [PMID: 33936095]
  80. Chemosphere. 2020 Apr;245:125585 [PMID: 31855760]
  81. J Physiol. 2017 Dec 15;595(24):7275-7309 [PMID: 29028112]
  82. J Neurochem. 2017 Aug;142 Suppl 2:178-187 [PMID: 28326544]
  83. J Asthma Allergy. 2021 Jun 14;14:641-662 [PMID: 34163178]
  84. Chem Biol Interact. 2019 Aug 1;308:130-136 [PMID: 31129131]
  85. Curr Neuropharmacol. 2013 May;11(3):315-35 [PMID: 24179466]
  86. Trop Med Infect Dis. 2023 Sep 26;8(10): [PMID: 37888585]
  87. EBioMedicine. 2022 Jul;81:104104 [PMID: 35728487]
  88. Med Princ Pract. 2013;22(5):418-26 [PMID: 23711993]
  89. Toxicol Rep. 2017 Oct 03;4:530-534 [PMID: 29657919]
  90. Biochimie. 2011 Mar;93(3):469-76 [PMID: 21094673]
  91. Analyst. 2018 Feb 12;143(4):920-929 [PMID: 29363680]
  92. Molecules. 2024 May 16;29(10): [PMID: 38792196]
  93. Life (Basel). 2024 Feb 07;14(2): [PMID: 38398742]
  94. Curr Neuropharmacol. 2016;14(1):101-15 [PMID: 26813123]
  95. ACS Omega. 2021 Jun 29;6(27):17609-17620 [PMID: 34278146]
  96. Curr Comput Aided Drug Des. 2011 Jun;7(2):146-57 [PMID: 21534921]
  97. Front Mol Neurosci. 2022 Sep 02;15:941467 [PMID: 36117917]
  98. J Environ Public Health. 2019 Sep 11;2019:3084501 [PMID: 31611921]
  99. Biomolecules. 2019 Oct 09;9(10): [PMID: 31601022]
  100. Cureus. 2024 Apr 16;16(4):e58416 [PMID: 38756263]
  101. Toxicol Appl Pharmacol. 1997 Aug;145(2):372-80 [PMID: 9266811]
  102. Biomolecules. 2021 Apr 15;11(4): [PMID: 33920972]
  103. Arterioscler Thromb Vasc Biol. 2019 May;39(5):965-977 [PMID: 30866659]
  104. Wiley Interdiscip Rev Comput Mol Sci. 2022 May-Jun;12(3): [PMID: 37293430]
  105. Int J Mol Sci. 2023 Sep 06;24(18): [PMID: 37762021]
  106. J Enzyme Inhib Med Chem. 2023 Dec;38(1):2225797 [PMID: 38061987]
  107. Molecules. 2015 Dec 19;20(12):22799-832 [PMID: 26703541]
  108. Nat Commun. 2017 Dec 22;8(1):2276 [PMID: 29273709]
  109. Cell Death Dis. 2016 Dec 15;7(12):e2521 [PMID: 27977009]
  110. Eur J Med Chem. 2024 Apr 15;270:116353 [PMID: 38579622]
  111. Sci Rep. 2018 Jan 22;8(1):1319 [PMID: 29358722]
  112. J Biol Chem. 2017 Jul 28;292(30):12667-12678 [PMID: 28607150]
  113. Neurosci Bull. 2018 Apr;34(2):369-381 [PMID: 29177767]
  114. Pharmaceuticals (Basel). 2018 May 11;11(2): [PMID: 29751602]
  115. Exp Eye Res. 2020 Jun;195:108003 [PMID: 32184102]
  116. Drug Chem Toxicol. 2020 Jul;43(4):423-428 [PMID: 30203679]
  117. Environ Sci Pollut Res Int. 2020 Jul;27(20):25689-25702 [PMID: 32350841]
  118. Thorac Cancer. 2015 Jul;6(4):390-8 [PMID: 26273392]
  119. Mini Rev Med Chem. 2020;20(8):703-715 [PMID: 31902355]
  120. Nucleic Acids Res. 2018 Apr 20;46(7):3298-3308 [PMID: 29534202]
  121. Sci Rep. 2023 Aug 17;13(1):13398 [PMID: 37592012]
  122. Foods. 2024 Jun 19;13(12): [PMID: 38928874]
  123. Molecules. 2023 Nov 27;28(23): [PMID: 38067537]
  124. J Biochem Mol Toxicol. 2017 Sep;31(9): [PMID: 28613396]
  125. Front Neurol. 2022 May 03;13:895316 [PMID: 35592472]
  126. Molecules. 2017 Sep 08;22(9): [PMID: 28885588]
  127. BMC Chem. 2024 May 11;18(1):99 [PMID: 38734638]
  128. Br J Pharmacol. 2005 Jan;144(1):88-97 [PMID: 15644872]
  129. Polymers (Basel). 2024 Jun 29;16(13): [PMID: 39000719]
  130. Transl Psychiatry. 2017 Mar 28;7(3):e1072 [PMID: 28350399]
  131. Int J Mol Sci. 2018 Oct 30;19(11): [PMID: 30380757]
  132. Int J Mol Sci. 2014 Jun 02;15(6):9809-25 [PMID: 24893223]
  133. Curr Issues Mol Biol. 2024 Feb 02;46(2):1318-1334 [PMID: 38392202]
  134. Int J Mol Sci. 2023 Jul 19;24(14): [PMID: 37511429]
  135. SLAS Discov. 2021 Dec;26(10):1355-1364 [PMID: 34269114]
  136. J Chem Theory Comput. 2022 Jul 12;18(7):4047-4069 [PMID: 35710099]
  137. J Immunol Res. 2022 Jul 21;2022:6051092 [PMID: 35915658]

MeSH Term

Humans
Molecular Docking Simulation
Animals
Cholinesterase Inhibitors
Cholinesterases
Polymorphism, Genetic

Chemicals

Cholinesterase Inhibitors
Cholinesterases

Word Cloud

Created with Highcharts 10.0.0CheEnzymemolecularcholinergicenzymegenomicdrugtherapyorganizationgenetranscriptionstructurebiogenesistransportprocessinglocalizationsignalingpolymorphismdiversediseaseinhibitorsplaysessentialrolenon-cholinergicfunctionspresentfertilized/unfertilizedeggsspermdifferentspeciesInclusioncriteriadatacollectionelectronicdatabasesNCBIGoogleScholarAChE/BChEbiologicalfunctioninfluencingfactorsactsreceptorhematopoiesisproteinadhesionamyloidfiberformationneuriteoutgrowthbonedevelopmentmaturationexplainingactivitysynapticneurotransmissionPolymorphismgenescorrelatesvariousdiseasesresponsesparticularchangeaccompaniescancerneurodegenerativecardiovascularLiteratureknowledgeindicatesimportanceinfluencebiochemicalpathwaystreatmentchangesindicatepossibilityefficientnewinhibitortargetmechanismsresearchareasChEdocking:Significantconsiderationsfutureperspectivesacetylcholinesterasetargetsorganisationsignalling

Similar Articles

Cited By